April 2014—Dako entered into a master framework agreement with Merck to develop companion diagnostic tests for oncology drugs currently in Merck’s development pipeline.
Dako, +45 25 46 10 83
April 2014—Dako entered into a master framework agreement with Merck to develop companion diagnostic tests for oncology drugs currently in Merck’s development pipeline.
Dako, +45 25 46 10 83